» Articles » PMID: 32807598

Metabolism-Associated Molecular Patterns (MAMPs)

Overview
Specialty Endocrinology
Date 2020 Aug 19
PMID 32807598
Citations 35
Authors
Affiliations
Soon will be listed here.
Abstract

Metabolic diseases pose a tremendous health threat in both developed and developing countries. The pathophysiology of metabolic diseases is complex but has been shown to be closely associated with sterile inflammation, which is initiated by various danger molecules derived from metabolic overload, such as oxidized low-density lipoproteins (OxLDLs), free fatty acids (FFAs), glucose, advanced glycation end products (AGEs), and cholesterol. These danger signals are sensed by pattern recognition receptors (PRRs) to activate proinflammatory signaling pathways and promote the release of proinflammatory mediators, leading to chronic low-grade inflammation. Although these harmful metabolic stimuli are generally regarded as damage-associated molecular patterns (DAMPs), a more specific definition and accurate classification for these DAMPs is still missing. In this opinion, we classify the harmful metabolic stimuli that can incite inflammatory responses and tissue damage via instigating PRRs as metabolism-associated molecular patterns (MAMPs), and we summarize their roles in metaflammation-mediated metabolic diseases.

Citing Articles

TNF inhibitors target a mevalonate metabolite/TRPM2/calcium signaling axis in neutrophils to dampen vasculitis in Behçet's disease.

Zhang M, Kang N, Yu X, Zhang X, Duan Q, Ma X Nat Commun. 2024; 15(1):9261.

PMID: 39461948 PMC: 11513106. DOI: 10.1038/s41467-024-53528-3.


SHP2-Triggered Endothelial Cell Activation Fuels Estradiol-Independent Endometrial Sterile Inflammation.

Pan J, Qu J, Fang W, Zhao L, Zheng W, Zhai L Adv Sci (Weinh). 2024; 11(41):e2403038.

PMID: 39234819 PMC: 11538683. DOI: 10.1002/advs.202403038.


Rhein targets macrophage SIRT2 to promote adipose tissue thermogenesis in obesity in mice.

Zhou R, Zhu Z, Xu P, Shen L, Wang Z, Xue Y Commun Biol. 2024; 7(1):1003.

PMID: 39152196 PMC: 11329635. DOI: 10.1038/s42003-024-06693-6.


The cellular and molecular targets of natural products against metabolic disorders: a translational approach to reach the bedside.

Shen X, Yang H, Yang Y, Zhu X, Sun Q MedComm (2020). 2024; 5(8):e664.

PMID: 39049964 PMC: 11266934. DOI: 10.1002/mco2.664.


Exploring the Gut Microbiome's Role in Inflammatory Bowel Disease: Insights and Interventions.

Gyriki D, Nikolaidis C, Stavropoulou E, Bezirtzoglou I, Tsigalou C, Vradelis S J Pers Med. 2024; 14(5).

PMID: 38793089 PMC: 11122163. DOI: 10.3390/jpm14050507.